Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 296

1.

Outcomes after surgery for functional tricuspid regurgitation: a systematic review and meta-analysis.

Veen KM, Etnel JRG, Quanjel TJM, Mokhles MM, Huygens SA, Rasheed M, Oei FBS, Ten Cate FJ, Bogers AJJC, Takkenberg JJM.

Eur Heart J Qual Care Clin Outcomes. 2019 Jul 8. pii: qcz032. doi: 10.1093/ehjqcco/qcz032. [Epub ahead of print]

PMID:
31287501
2.

Effect of alcohol dosage on long-term outcomes after alcohol septal ablation in patients with hypertrophic cardiomyopathy.

Liebregts M, Vriesendorp PA, Steggerda RC, Schinkel AF, Balt JC, Ten Cate FJ, Michels M, Ten Berg JM.

Catheter Cardiovasc Interv. 2016 Nov 15;88(6):945-952. doi: 10.1002/ccd.26448. Epub 2016 Mar 4.

PMID:
26946355
3.

Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Vriesendorp PA, Schinkel AF, Liebregts M, Theuns DA, van Cleemput J, Ten Cate FJ, Willems R, Michels M.

Circ Arrhythm Electrophysiol. 2015 Aug;8(4):829-35. doi: 10.1161/CIRCEP.114.002553. Epub 2015 Apr 28.

PMID:
25922410
4.

Long-term benefit of myectomy and anterior mitral leaflet extension in obstructive hypertrophic cardiomyopathy.

Vriesendorp PA, Schinkel AF, Soliman OI, Kofflard MJ, de Jong PL, van Herwerden LA, Ten Cate FJ, Michels M.

Am J Cardiol. 2015 Mar 1;115(5):670-5. doi: 10.1016/j.amjcard.2014.12.017. Epub 2014 Dec 18.

PMID:
25591899
5.

CEUS.

ten Cate FJ.

Swiss Med Wkly. 2015 Jan 14;145:w14069. doi: 10.4414/smw.2015.14069. eCollection 2015. No abstract available.

6.

Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.

Vriesendorp PA, Liebregts M, Steggerda RC, Schinkel AF, Willems R, Ten Cate FJ, van Cleemput J, Ten Berg JM, Michels M.

JACC Heart Fail. 2014 Dec;2(6):630-6. doi: 10.1016/j.jchf.2014.06.012. Epub 2014 Oct 22.

7.

Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.

Vriesendorp PA, Schinkel AF, de Groot NM, van Domburg RT, Ten Cate FJ, Michels M.

Clin Cardiol. 2014 Aug;37(8):493-8. doi: 10.1002/clc.22293. Epub 2014 Jul 4.

8.

Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations.

van Dijk SJ, Boontje NM, Heymans MW, Ten Cate FJ, Michels M, Dos Remedios C, Dooijes D, van Slegtenhorst MA, van der Velden J, Stienen GJ.

Pflugers Arch. 2014 Aug;466(8):1619-33. doi: 10.1007/s00424-013-1391-0. Epub 2013 Nov 2.

PMID:
24186209
9.

MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.

Kuster DW, Mulders J, Ten Cate FJ, Michels M, Dos Remedios CG, da Costa Martins PA, van der Velden J, Oudejans CB.

J Mol Cell Cardiol. 2013 Dec;65:59-66. doi: 10.1016/j.yjmcc.2013.09.012. Epub 2013 Sep 29.

PMID:
24083979
10.

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.

Vriesendorp PA, Schinkel AF, Van Cleemput J, Willems R, Jordaens LJ, Theuns DA, van Slegtenhorst MA, de Ravel TJ, ten Cate FJ, Michels M.

Am Heart J. 2013 Sep;166(3):496-502. doi: 10.1016/j.ahj.2013.06.009. Epub 2013 Jul 16.

PMID:
24016499
11.

Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.

Witjas-Paalberends ER, Piroddi N, Stam K, van Dijk SJ, Oliviera VS, Ferrara C, Scellini B, Hazebroek M, ten Cate FJ, van Slegtenhorst M, dos Remedios C, Niessen HW, Tesi C, Stienen GJ, Heymans S, Michels M, Poggesi C, van der Velden J.

Cardiovasc Res. 2013 Aug 1;99(3):432-41. doi: 10.1093/cvr/cvt119. Epub 2013 May 13.

PMID:
23674513
12.

Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation.

Vriesendorp PA, Van Mieghem NM, Vletter WB, Ten Cate FJ, de Jong PL, Schinkel AF, Michels M.

Neth Heart J. 2013 May;21(5):245-8. doi: 10.1007/s12471-013-0393-z.

13.

Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.

Sequeira V, Wijnker PJ, Nijenkamp LL, Kuster DW, Najafi A, Witjas-Paalberends ER, Regan JA, Boontje N, Ten Cate FJ, Germans T, Carrier L, Sadayappan S, van Slegtenhorst MA, Zaremba R, Foster DB, Murphy AM, Poggesi C, Dos Remedios C, Stienen GJ, Ho CY, Michels M, van der Velden J.

Circ Res. 2013 May 24;112(11):1491-505. doi: 10.1161/CIRCRESAHA.111.300436. Epub 2013 Mar 18. Erratum in: Circ Res. 2013 Sep 27;113(8):e87.

14.

Diagnostic uncertainties and future perspectives in noncompaction cardiomyopathy.

Soliman OI, Geleijnse ML, Caliskan K, Vletter WB, Ten Cate FJ.

Expert Opin Med Diagn. 2012 May;6(3):221-33. doi: 10.1517/17530059.2012.673582. Epub 2012 Mar 28.

PMID:
23480687
15.

Assessment of subendocardial contractile function in aortic stenosis: a study using speckle tracking echocardiography.

van Dalen BM, Tzikas A, Soliman OI, Heuvelman HJ, Vletter WB, Ten Cate FJ, Geleijnse ML.

Echocardiography. 2013 Mar;30(3):293-300. doi: 10.1111/echo.12051. Epub 2013 Jan 24.

PMID:
23347129
16.

Geometric errors of the pulsed-wave Doppler flow method in quantifying degenerative mitral valve regurgitation: a three-dimensional echocardiography study.

Ren B, de Groot-de Laat LE, McGhie J, Vletter WB, Ten Cate FJ, Geleijnse ML.

J Am Soc Echocardiogr. 2013 Mar;26(3):261-9. doi: 10.1016/j.echo.2012.10.011. Epub 2012 Dec 7.

PMID:
23228655
17.

Diastolic abnormalities in normal phenotype hypertrophic cardiomyopathy gene carriers: a study using speckle tracking echocardiography.

Kauer F, van Dalen BM, Michels M, Soliman OI, Vletter WB, van Slegtenhorst M, ten Cate FJ, Geleijnse ML.

Echocardiography. 2013 May;30(5):558-63. doi: 10.1111/echo.12076. Epub 2012 Dec 10.

PMID:
23228071
18.

Regional left ventricular rotation and back-rotation in patients with reverse septal curvature hypertrophic cardiomyopathy.

Kauer F, van Dalen BM, Soliman OI, van der Zwaan HB, Vletter WB, Schinkel AF, ten Cate FJ, Geleijnse ML.

Eur Heart J Cardiovasc Imaging. 2013 May;14(5):435-42. doi: 10.1093/ehjci/jes163. Epub 2012 Aug 16.

PMID:
22898715
19.

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.

Schinkel AF, Vriesendorp PA, Sijbrands EJ, Jordaens LJ, ten Cate FJ, Michels M.

Circ Heart Fail. 2012 Sep 1;5(5):552-9. Epub 2012 Jul 20. Review.

PMID:
22821634
20.

Assessment of subclinical atherosclerosis using contrast-enhanced ultrasound.

van den Oord SC, ten Kate GL, Akkus Z, Renaud G, Sijbrands EJ, ten Cate FJ, van der Lugt A, Bosch JG, de Jong N, van der Steen AF, Schinkel AF.

Eur Heart J Cardiovasc Imaging. 2013 Jan;14(1):56-61. doi: 10.1093/ehjci/jes109. Epub 2012 May 29.

PMID:
22645206
21.

The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy.

Kolder IC, Michels M, Christiaans I, Ten Cate FJ, Majoor-Krakauer D, Danser AH, Lekanne Deprez RH, Tanck M, Wilde AA, Bezzina CR, Dooijes D.

Eur J Hum Genet. 2012 Oct;20(10):1071-7. doi: 10.1038/ejhg.2012.48. Epub 2012 May 9.

22.

Far-wall pseudoenhancement during contrast-enhanced ultrasound of the carotid arteries: clinical description and in vitro reproduction.

ten Kate GL, Renaud GG, Akkus Z, van den Oord SC, ten Cate FJ, Shamdasani V, Entrekin RR, Sijbrands EJ, de Jong N, Bosch JG, Schinkel AF, van der Steen AF.

Ultrasound Med Biol. 2012 Apr;38(4):593-600. doi: 10.1016/j.ultrasmedbio.2011.12.019. Epub 2012 Feb 15.

PMID:
22341054
23.

EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography.

Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, Faletra FF, Franke A, Hung J, de Isla LP, Kamp O, Kasprzak JD, Lancellotti P, Marwick TH, McCulloch ML, Monaghan MJ, Nihoyannopoulos P, Pandian NG, Pellikka PA, Pepi M, Roberson DA, Shernan SK, Shirali GS, Sugeng L, Ten Cate FJ, Vannan MA, Zamorano JL, Zoghbi WA; American Society of Echocardiography; European Association of Echocardiography.

Eur Heart J Cardiovasc Imaging. 2012 Jan;13(1):1-46. doi: 10.1093/ehjci/jer316. No abstract available.

24.

Surgical treatment of residual systolic anterior motion after otherwise successful percutaneous transluminal septal myocardial ablation: a case report.

Hjortnaes J, Leemans PA, ten Cate FJ, van Herwerden LA.

J Thorac Cardiovasc Surg. 2012 Aug;144(2):506-8. doi: 10.1016/j.jtcvs.2011.11.020. Epub 2012 Jan 11. No abstract available.

25.

EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography.

Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, Faletra FF, Franke A, Hung J, de Isla LP, Kamp O, Kasprzak JD, Lancellotti P, Marwick TH, McCulloch ML, Monaghan MJ, Nihoyannopoulos P, Pandian NG, Pellikka PA, Pepi M, Roberson DA, Shernan SK, Shirali GS, Sugeng L, Ten Cate FJ, Vannan MA, Zamorano JL, Zoghbi WA; American Society of Echocardiography; European Association of Echocardiography.

J Am Soc Echocardiogr. 2012 Jan;25(1):3-46. doi: 10.1016/j.echo.2011.11.010. No abstract available.

PMID:
22183020
26.

Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function.

van Dijk SJ, Paalberends ER, Najafi A, Michels M, Sadayappan S, Carrier L, Boontje NM, Kuster DW, van Slegtenhorst M, Dooijes D, dos Remedios C, ten Cate FJ, Stienen GJ, van der Velden J.

Circ Heart Fail. 2012 Jan;5(1):36-46. doi: 10.1161/CIRCHEARTFAILURE.111.963702. Epub 2011 Dec 16.

PMID:
22178992
27.

Mortality risk of untreated myosin-binding protein C-related hypertrophic cardiomyopathy: insight into the natural history.

Nannenberg EA, Michels M, Christiaans I, Majoor-Krakauer D, Hoedemaekers YM, van Tintelen JP, Lombardi MP, ten Cate FJ, Schinkel AF, Tijssen JG, van Langen IM, Wilde AA, Sijbrands EJ.

J Am Coll Cardiol. 2011 Nov 29;58(23):2406-14. doi: 10.1016/j.jacc.2011.07.044. Erratum in: J Am Coll Cardiol. 2012 Feb 14;59(7):702.

28.

Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation.

Timmer SA, Knaapen P, Germans T, Lubberink M, Dijkmans PA, Vonk-Noordegraaf A, Ten Berg JM, Ten Cate FJ, Lammertsma AA, van Rossum AC.

J Card Fail. 2011 Oct;17(10):827-31. doi: 10.1016/j.cardfail.2011.06.375. Epub 2011 Jul 23.

PMID:
21962421
29.

New Scores for the Assessment of Mitral Stenosis Using Real-Time Three-Dimensional Echocardiography.

Soliman OI, Anwar AM, Metawei AK, McGhie JS, Geleijnse ML, Ten Cate FJ.

Curr Cardiovasc Imaging Rep. 2011 Oct;4(5):370-377. Epub 2011 Jul 9.

30.

Contrast echocardiography improves interobserver agreement for wall motion score index and correlation with ejection fraction.

Galema TW, van de Ven AR, Soliman OI, van Domburg RT, Vletter WB, van Dalen BM, Nemes A, ten Cate FJ, Geleijnse ML.

Echocardiography. 2011 May;28(5):575-81. doi: 10.1111/j.1540-8175.2010.01379.x. Epub 2011 Apr 29.

PMID:
21535116
31.

Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.

Timmer SA, Knaapen P, Germans T, Dijkmans PA, Lubberink M, Ten Berg JM, Ten Cate FJ, Rüssel IK, Götte MJ, Lammertsma AA, van Rossum AC.

Am J Physiol Heart Circ Physiol. 2011 Jul;301(1):H129-37. doi: 10.1152/ajpheart.00077.2011. Epub 2011 Apr 13.

32.

More on advances in imaging angiogenesis and inflammation in atherosclerosis.

Schinkel AF, Staub D, Ten Kate GL, van den Oord SC, Ten Cate FJ, Sijbrands EJ, Feinstein SB.

Thromb Haemost. 2011 May;105(5):920-1. doi: 10.1160/TH11-02-0131. Epub 2011 Mar 24. No abstract available.

PMID:
21437350
33.

Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury.

Timmer SA, Germans T, Götte MJ, Rüssel IK, Lubberink M, Ten Berg JM, Ten Cate FJ, Lammertsma AA, Knaapen P, van Rossum AC.

Am J Cardiol. 2011 May 15;107(10):1522-8. doi: 10.1016/j.amjcard.2011.01.029. Epub 2011 Mar 4.

PMID:
21377644
34.

Diagnostic value of rigid body rotation in noncompaction cardiomyopathy.

van Dalen BM, Caliskan K, Soliman OI, Kauer F, van der Zwaan HB, Vletter WB, van Vark LC, Ten Cate FJ, Geleijnse ML.

J Am Soc Echocardiogr. 2011 May;24(5):548-55. doi: 10.1016/j.echo.2011.01.002. Epub 2011 Feb 22.

PMID:
21345651
35.

Noninvasive imaging of the vulnerable atherosclerotic plaque.

ten Kate GL, Sijbrands EJ, Staub D, Coll B, ten Cate FJ, Feinstein SB, Schinkel AF.

Curr Probl Cardiol. 2010 Nov;35(11):556-91. doi: 10.1016/j.cpcardiol.2010.09.002. Review.

PMID:
20974314
36.

Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients.

Schaer BA, Osswald S, Di Valentino M, Soliman OI, Sticherling C, ten Cate FJ, Jordaens L, Theuns DA.

Eur J Heart Fail. 2010 Dec;12(12):1325-32. doi: 10.1093/eurjhf/hfq171. Epub 2010 Oct 5.

37.

Paradoxical effects of interatrial conduction delay in a hypertrophic cardiomyopathy patient in the long-term: time is a great healer.

Bauernfeind T, Caliskan K, Vletter WB, Ten Cate FJ, Dabiri L, de Groot N, Jordaens L, Szili-Torok T.

J Cardiovasc Electrophysiol. 2011 May;22(5):587-9. doi: 10.1111/j.1540-8167.2010.01893.x. Epub 2010 Aug 31.

PMID:
20812930
38.

Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques.

Staub D, Schinkel AF, Coll B, Coli S, van der Steen AF, Reed JD, Krueger C, Thomenius KE, Adam D, Sijbrands EJ, ten Cate FJ, Feinstein SB.

JACC Cardiovasc Imaging. 2010 Jul;3(7):761-71. doi: 10.1016/j.jcmg.2010.02.007. Review.

39.

Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?

ten Kate GL, Sijbrands EJ, Valkema R, ten Cate FJ, Feinstein SB, van der Steen AF, Daemen MJ, Schinkel AF.

J Nucl Cardiol. 2010 Oct;17(5):897-912. doi: 10.1007/s12350-010-9263-x. Review.

40.

The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy.

Hoedemaekers YM, Caliskan K, Michels M, Frohn-Mulder I, van der Smagt JJ, Phefferkorn JE, Wessels MW, ten Cate FJ, Sijbrands EJ, Dooijes D, Majoor-Krakauer DF.

Circ Cardiovasc Genet. 2010 Jun;3(3):232-9. doi: 10.1161/CIRCGENETICS.109.903898. Epub 2010 Jun 8.

PMID:
20530761
41.

Contrast echocardiography: mechanism of action, safety and clinical applications.

Soliman OI, De Jong N, Van Der Zwaan HB, Galema TW, Vletter WB, Van Dalen BM, Schinkel AF, Ten Cate FJ, Geleijnse ML.

Minerva Cardioangiol. 2010 Jun;58(3):343-55. Review.

PMID:
20485240
42.

[Evaluation of the mitral valve by transthoracic real-time three-dimensional echocardiography].

Nemes A, Geleijnse ML, Soliman OI, Vletter WB, McGhie JS, Forster T, Ten Cate FJ.

Orv Hetil. 2010 May 23;151(21):854-63. doi: 10.1556/OH.2010.28874. Review. Hungarian.

PMID:
20462845
43.

Incidence, pathophysiology, and treatment of complications during dobutamine-atropine stress echocardiography.

Geleijnse ML, Krenning BJ, Nemes A, van Dalen BM, Soliman OI, Ten Cate FJ, Schinkel AF, Boersma E, Simoons ML.

Circulation. 2010 Apr 20;121(15):1756-67. doi: 10.1161/CIRCULATIONAHA.109.859264. Review. No abstract available.

PMID:
20404267
44.

Contrast-enhanced ultrasound for imaging vasa vasorum: comparison with histopathology in a swine model of atherosclerosis.

Schinkel AF, Krueger CG, Tellez A, Granada JF, Reed JD, Hall A, Zang W, Owens C, Kaluza GL, Staub D, Coll B, Ten Cate FJ, Feinstein SB.

Eur J Echocardiogr. 2010 Sep;11(8):659-64. doi: 10.1093/ejechocard/jeq048. Epub 2010 Apr 12.

PMID:
20385655
45.

Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution.

ten Cate FJ, Soliman OI, Michels M, Theuns DA, de Jong PL, Geleijnse ML, Serruys PW.

Circ Heart Fail. 2010 May;3(3):362-9. doi: 10.1161/CIRCHEARTFAILURE.109.862359. Epub 2010 Mar 23.

PMID:
20332420
46.

Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.

Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.

Am J Cardiol. 2010 Jan 1;105(1):105-11. doi: 10.1016/j.amjcard.2009.08.659. Epub 2009 Nov 18.

PMID:
20102900
47.

Cardiomyopathies: a revolution in molecular medicine and cardiac imaging.

Ten Cate FJ.

Neth Heart J. 2009 Dec;17(12):456-7. No abstract available.

48.

Thrombus in a normal left ventricle: a cardiac manifestation of pheochromocytoma.

Wiyono SA, Vletter WB, Soliman OI, ten Cate FJ, Geleijnse ML.

Echocardiography. 2010 Feb;27(2):195-7. doi: 10.1111/j.1540-8175.2009.01041.x. Epub 2010 Jan 13.

PMID:
20070355
49.

Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy.

Timmer SA, Germans T, Götte MJ, Rüssel IK, Dijkmans PA, Lubberink M, ten Berg JM, ten Cate FJ, Lammertsma AA, Knaapen P, van Rossum AC.

Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):779-88. doi: 10.1007/s00259-009-1350-3. Epub 2010 Jan 13.

PMID:
20069294
50.

Potential of [11C]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy.

Timmer SA, Lubberink M, Germans T, Götte MJ, ten Berg JM, ten Cate FJ, van Rossum AC, Lammertsma AA, Knaapen P.

J Nucl Cardiol. 2010 Apr;17(2):264-75. doi: 10.1007/s12350-009-9181-y. Epub 2009 Dec 29.

PMID:
20039151

Supplemental Content

Loading ...
Support Center